Aquestive Therapeutics, Inc. · NASDAQ:AQST
Aquestive Therapeutics, Inc. shareholders
As of Jun 30, 2026, 181 institutions reported holding Aquestive Therapeutics, Inc., 57.4% of its shares. Largest: Bratton Capital Management, L.P., BlackRock and Rtw Investments, LP. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Aquestive Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Bratton Capital Management, L.P. | 9.81M | 7.8% | no change | Aug 11, 2026 |
| BlackRock | 8.07M | 6.4% | +560K | Aug 7, 2026 |
| Rtw Investments, LP | 7.43M | 5.9% | no change | Aug 14, 2026 |
| Vanguard | 6.01M | 4.8% | +197K | Aug 13, 2026 |
| Federated Hermes, Inc. | 3.11M | 2.5% | +172K | Aug 12, 2026 |
| State Street | 2.93M | 2.3% | +382K | Aug 7, 2026 |
| Geode Capital | 2.62M | 2.1% | +215K | Aug 12, 2026 |
| Samsara Biocapital, LLC | 2.5M | 2.0% | no change | Aug 14, 2026 |
| Bank of America | 1.67M | 1.3% | −737K | Aug 14, 2026 |
| Sio Capital Management, LLC | 1.49M | 1.2% | −437K | Aug 14, 2026 |